Statistics for ALX Oncology Holdings (id:8199 ALXO)
Valuation metrics
Market cap
64.35M
Enterprise value
-66,869,412.00
Trailing P/E (ttm)
-0.38
Forward P/E
-0.45
PEG ratio
-0.45
Price/Sales (ttm)
Price/Book (mrq)
0.47
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.42
Overview
Shares outstanding
52.74M
Float
27.14M
Shares short
7.84M
% Held by insiders
0.02%
% Held by institutions
0.92%
Average volume (10 days)
934.22K
Average volume (90 days)
Price summary
52-Week low
1.19
52-Week high
17.82
52-Week change
-529.08%
Beta
1.04
50-Day moving average
1.69
200-Day moving average
8.06
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-49.24%
Return on equity
-98.94%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-159,012,000.00
Net income to common (ttm)
-151,159,008.00
Diluted EPS (ttm)
-2.97
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
148.57M
Total cash per share (mrq)
2.82
Total debt (mrq)
17.36M
Total Debt/Equity (mrq)
12.69
Current ratio (mrq)
482.10%
Book value per share (mrq)
2.59
Cash flow
Cash flow statement
-129,544,000.00
Levered free cash flow (LFCF)
-74,554,248.00